We're all set for a new experience. To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open5,826
High5,897
Low5,665
Prev. Close5,831
Avg. Traded Price5,839.87
Volume9,403

MARKET DEPTH

info2
Total bid2.00
Total ask0.00
OrdersQtyBid
225831
000
000
000
000
AskQtyOrders
000
000
000
000
000

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

5,665.0016 hours ago
5,897.0015 hours ago
arrow

LOWER/UPPER CIRCUITS

4,672.00
7,007.00
arrow
Procter And Gamble Health Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Net Profit,rose 2.15% in the last year to ₹234.41 Cr. Its sector's average net profit growth for the last fiscal year was 38.6%.
notePrice to Earning Ratio,is 38.59, lower than its sector PE ratio of 41.83.
noteReturn on Equity(ROE),for the last financial year was 43.65%, more than 20% in the last financial year, indicating an efficient use of shareholder's capital to generate profit.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 4.98%
Net profit growth 5Y CAGR : 19.56%
Procter And Gamble Health Ltd Top mutual funds holding
arrow
Procter & Gamble Health Limited (formerly Merck Limited) was set up in India as one of Merck’s Asian subsidiaries in 1967. It was also the first Merck Group Company to go public in the year 1981. Till 2018 the Company was operating in all businesses included in the pharmaceuticals and chemicals businesses in the country. On December 1st 2018 it successfully completed the acquisition of Merck’s Consumer Health business further to approval of all relevant regulatory authorities and the fulfilment of other customary closing conditions.
personal

Grow your wealth with more research recommendations

+91